Cargando…
Analysis of Key Clinical Variables and Radiological Manifestations Associated with the Treatment Response of Patients with Brain Metastases to Stereotactic Radiosurgery
Background: Stereotactic radiosurgery (SRS) is considered a promising treatment for brain metastases (BM) with better healing efficacy, relatively faster treatment time, and lower neurotoxicity, which can achieve local control rates above 70%. Although SRS improves the local control of BM, this may...
Autores principales: | Du, Peng, Chen, Hongyi, Shen, Li, Liu, Xiao, Chen, Jiawei, Wu, Xuefan, Yu, Tonggang, Geng, Daoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369562/ https://www.ncbi.nlm.nih.gov/pubmed/35956144 http://dx.doi.org/10.3390/jcm11154529 |
Ejemplares similares
-
Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: A machine learning model
por: Du, Peng, et al.
Publicado: (2023) -
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013) -
Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
por: Peña-Pino, Isabela, et al.
Publicado: (2023) -
Preoperative Stereotactic Radiosurgery for Brain Metastases
por: Routman, David M., et al.
Publicado: (2018) -
Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017)